1. Home
  2. TOL vs MEDP Comparison

TOL vs MEDP Comparison

Compare TOL & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toll Brothers Inc.

TOL

Toll Brothers Inc.

HOLD

Current Price

$139.43

Market Cap

14.0B

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$416.83

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOL
MEDP
Founded
1967
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0B
11.7B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
TOL
MEDP
Price
$139.43
$416.83
Analyst Decision
Buy
Hold
Analyst Count
17
12
Target Price
$164.44
$473.17
AVG Volume (30 Days)
840.6K
455.2K
Earning Date
05-19-2026
04-22-2026
Dividend Yield
0.72%
N/A
EPS Growth
N/A
20.98
EPS
2.19
4.28
Revenue
$7,143,258,000.00
N/A
Revenue This Year
N/A
$13.19
Revenue Next Year
$6.01
$7.75
P/E Ratio
$64.89
$98.09
Revenue Growth
N/A
N/A
52 Week Low
$100.92
$284.10
52 Week High
$168.36
$628.92

Technical Indicators

Market Signals
Indicator
TOL
MEDP
Relative Strength Index (RSI) 44.50 36.57
Support Level $133.98 $382.68
Resistance Level $139.64 $485.13
Average True Range (ATR) 3.86 17.47
MACD -0.35 -10.02
Stochastic Oscillator 5.37 27.75

Price Performance

Historical Comparison
TOL
MEDP

About TOL Toll Brothers Inc.

Toll Brothers Inc is the luxury homebuilder in the USA, operating in over 60 markets across 24 states. The Fort Washington, Pennsylvania-headquartered homebuilder caters to affluent first-time, move-up, active-adult, and second-homebuyers. Toll Brothers has shifted in recent years to a greater mix of speculative, or "quick move-in" homes. The homebuilder has also expanded its price points, with a greater emphasis on "affordable luxury. Traditional homebuilding accounts for the majority of Toll Brothers' earnings, but the firm also offers ancillary mortgage, title, insurance, and other services.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: